null
ChEBI ID: 22327
Member | Definition | Role |
---|---|---|
2,2'-thiodiethanol | A diol that is pentane-1,5-diol in which the methylene group at position 3 is replaced by a sulfur atom | thiodiglycol |
cimetidine | A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach. | cimetidine |
dibutyl sulfide | Dibutyl sulfide | |
dimethyl sulfide | A methyl sulfide in which the sulfur atom is substituted by two methyl groups. It is produced naturally by some marine algae. | dimethyl sulfide |
dipropyl sulfide | Dipropyl sulfide | |
letosteine | A dicarboxylic acid monoester that is the monoethyl ester of 2-{2-[(carboxymethyl)sulfanyl]ethyl}-1,3-thiazolidine-4-carboxylic acid. A mucolytic used in the treatment of chronic bronchopneumopathies and related conditions. | letosteine |
methional | 3-methylthiopropanal | |
methionol | An alkyl sulfide that is propan-1-ol substituted by a methylsulfanyl group at position 3. It is a volatile compound found in wines and produced during fermentation. | 3-methylthiopropanol |
methomyl | A carbamate ester obtained by the formal condensation of methylcarbamic acid with the hydroxy group of 1-(methylsulfanyl)acetaldoxime. | methomyl |
methylthioethanol | A primary alcohol that is the S-methyl derivative of mercaptoethanol. It is found as a volatile component in Cucumis melo Var. cantalupensis. | 2-methylthioethanol |
montelukast | montelukast | |
tiadenol | tiadenol |
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 5,993 (51.43) | 18.7374 |
1990's | 2,011 (17.26) | 18.2507 |
2000's | 1,888 (16.20) | 29.6817 |
2010's | 1,356 (11.64) | 24.3611 |
2020's | 405 (3.48) | 2.80 |
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 2,307 (18.39%) | 5.53% |
Reviews | 789 (6.29%) | 6.00% |
Case Studies | 1,101 (8.78%) | 4.05% |
Observational | 22 (0.18%) | 0.25% |
Other | 8,327 (66.37%) | 84.16% |